Skip to main

9 Meters Biopharma

NMTR is nowNMTRQ
NMTR logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More

Frequently Asked Questions (FAQ)

As of Aug 10, 2025, the market cap for NMTR stock is $599.69M

The current P/E ratio for NMTR stock is 34.98

The 52-week high for NMTR stock is $7.27. The current NMTR stock price $undefined is 100.00% below its 52-week high

The 52-week low for NMTR stock is $5.02. The current NMTR stock price $undefined has increased 100.00% from its 52-week low

Yes, the NMTR stock pays a dividend to its shareholders. The current dividend yield is 12.05%

How to buy NMTR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NMTR stock

    Navigate to the Explore page. Then, type NMTR into the search bar. When you see NMTR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NMTR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

9 Meters Biopharma Stock Earnings

The value each NMTR share was expected to gain vs. the value that each NMTR share actually gained.

NMTR (NMTR) reported Q1 2023 earnings per share (EPS) of -$1.02, missing estimates of -$0.78 by 30.77%. In the same quarter last year, NMTR's earnings per share (EPS) was -$0.80. NMTR is expected to release next earnings on 05/15/2023, with an earnings per share (EPS) estimate of $0.

Buy NMTR Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.